Results 271 to 280 of about 576,149 (314)
Some of the next articles are maybe not open access.
Cardiac dysfunction in critical illness
Current Opinion in Anaesthesiology, 2018Sepsis and septic shock are prevalent conditions that are likely to increase in prevalence in the future. Given the high mortality and morbidity associated with sepsis and sepsis-induced cardiac dysfunction, we must continue to make advances in knowledge of the complex physiologic interactions and how we may target specific mediators for potential ...
Allison, Dalton, Sajid, Shahul
openaire +2 more sources
Lung Function in Cardiac Dysfunction
Archivos de Bronconeumología ((English Edition)), 2004The alterations in lung function caused by heart failure were first described some decades ago. The advent of new tools for the diagnosis and investigation of heart disease, such as echocardiography, has subsequently made it possible to classify cardiac dysfunction with greater precision.
S, Ricart +7 more
openaire +2 more sources
Cardiac dysfunction in the CABG patient
Current Opinion in Pharmacology, 2012Coronary revascularization with conventional CABG has the best evidence for improving outcome in patients with ischemic heart disease. Three main complications after CABG are myocardial infarction, heart failure and atrial fibrillation. Although preoperative statin and aspirin therapy are established treatment for post CABG myocardial infarction when ...
openaire +2 more sources
Erectile dysfunction in the cardiac patient
Current Urology Reports, 2003Erectile dysfunction (ED) is a common problem in men over 40-50 years of age. Risk factors include: diabetes, lipid abnormalities, smoking, hypertension, obesity, and lack of physical activity. Oral phosphodiesterase-5 inhibitors appear effective and safe in most cardiac patients.
openaire +3 more sources
Cardiac function and dysfunction in the fetus
Echocardiography, 2017Evaluation of fetal cardiac function is one of the most important components of fetal echocardiography. Fetal cardiac dysfunction is closely linked to risk of intrauterine fetal demise, in many, but not all cases is indicative of worse postnatal prognosis and may prompt the use of medications or interventions to optimize outcomes.
Luke Eckersley, Lisa K. Hornberger
openaire +2 more sources
Subclinical Cardiac Dysfunction in Sarcoidosis
Chest, 1991Clinically apparent myocardial disease is infrequent in sarcoidosis. However, autopsy data show myocardial involvement in up to 30 percent of patients. Unexplained exertional symptomatology is a common complaint in patients with sarcoidosis. In this study, we investigated whether abnormal cardiac function might limit exercise performance in patients ...
W J, Gibbons +8 more
openaire +2 more sources
CARDIAC AND NEUROLOGIC DYSFUNCTION IN SARCOIDOSIS
Clinics in Chest Medicine, 1997Clinically apparent involvement of the heart and nervous system occurs in a relatively small number of patients with sarcoidosis. The diagnosis of myocardial and neurological sarcoidosis is difficult because anatomic presence of granulomas without clinical dysfunction is an important feature of sarcoidosis.
openaire +2 more sources
MECHANISMS OF CARDIAC DYSFUNCTION IN SEPSIS
Shock, 2022ABSTRACT Studies in animal models of sepsis have elucidated an intricate network of signaling pathways that lead to the dysregulation of myocardial Ca2+ handling and subsequently to a decrease in cardiac contractile force, in a sex- and model-dependent manner. After challenge with a lethal dose of LPS, male animals show a decrease in cellular
openaire +2 more sources
Cardiac dysfunction after burns
Burns, 2008Using transoesophageal echocardiography (TEE) we investigated the occurrence, and the association of possible abnormalities of motion of the regional wall of the heart (WMA) or diastolic dysfunction with raised troponin concentrations, or both during fluid resuscitation in patients with severe burns.Ten consecutive adults (aged 36-89 years, two women ...
Z, Bak +4 more
openaire +2 more sources
Cardiac dysfunction associated with trastuzumab
Expert Opinion on Drug Safety, 2006The HER2/neu gene is amplified in approximately 25% of breast cancers, leading to HER2 protein overexpression and shortened overall survival and time to relapse. Trastuzumab is a humanised, monoclonal antibody against HER2, which improves survival for women with metastatic HER2-overexpressing breast cancer and reduces the risk of recurrence in women ...
Karen Lisa, Smith +2 more
openaire +2 more sources